New leukemia treatment uses disabled HIV to save girl’s life

OPACC
Dec 18, 2012
1 min read

A new leukemia treatment, which showed success in adults during its debut, is now making the same headway in children, states a report from the CBS Evening News. The process uses disabled human immunodeficiency virus (HIV)–the virus that causes AIDS–to modify T-cells in a way which allows them to track and target leukemia cells.

Untreated GHD Linked to Adverse Outcomes in Childhood Cancer Survivors

NCCN Guidelines Now Recommend Naxitamab for High-Risk Neuroblastoma

Common appliance raises kids’ cancer risk nearly twice as much as adults’

How protein-slayer drugs could beat some of the cruellest cancers

Childhood brain tumors develop early in highly specialized nerve cells, research reveals

Pediatric Brain Tumor Risk Increases With CT Radiation Exposure

AI Predicts Pediatric Brain Tumor Relapse With Surprising Accuracy

Study identifies how malaria can lead to childhood cancer

'Phenomenal' - study hailed a significant milestone in child cancer care

FDA Grants Breakthrough Therapy Designation for BrainChild Bio’s B7-H3 CAR T-Cell Therapy for Incurable Pediatric Brain Tumors

Recent Posts